|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02633 JACOBSON PHARMA
Nominal 
1.290 +0.020 (+1.575%) | 2025/09 - Interim HKD(K$) | 2025/03 HKD(K$) | 2024/03 HKD(K$) | 2023/03 HKD(K$) | 2022/03 HKD(K$) | |
| Net Cash from / (used in) Operating Activities | -- | 526,777 | 484,363 | 630,090 | 406,942 |
| Net Cash from / (used in) Investing Activities | -- | (297,758) | 43,342 | (134,983) | (49,938) |
| Net Cash from / (used in) Financing Activities | -- | (131,296) | (1,053,255) | (36,598) | (357,888) |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 97,723 | (525,550) | 458,509 | (884) |
| Cash & Cash Equivalents at beginning of period | -- | 411,937 | 936,418 | 478,653 | 480,350 |
| Effect of Foreign Exchange Rate Changes | -- | (615) | 1,069 | (744) | (813) |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 509,045 | 411,937 | 936,418 | 478,653 |
| Remarks: | Real time quote last updated: 12/12/2025 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 142,035 |
| %Change | 1.244% |
| EPS / (LPS) | HKD 0.071 |
| NBV Per Share ($) | HKD 1.117 |